About this trial
This study aims to optimize a treatment package for the relapse prevention treatment of AN. In the Preparation Phase, we examined accessibility and feasibility of the treatment package.
In the current Optimization Phase, we will identify which components of treatment contribute to positive outcomes after acute hospitalization. We will carefully evaluate maintenance of remission, measured by rate of weight loss and end-of-trial status.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Diagnosis of Anorexia Nervosa at hospital admission
Medically Stable
Internet capability with videoconferencing
Weight restored (BMI > 19 kg/m2) at New York State Psychiatric Institute
Disqualifiers
Current substance use or other comorbid disorder requiring specialized treatment
Pregnancy
Imminent risk of suicide
Serious medical illness
Trial design
Factorial
Treatments tested in this trial
Relapse Prevention and Changing Habits (REACH+)
BehavioralPsychotherapy
Treatment groups
26
Treatment groupsSee each treatment group below.
Trial outcomes
Primary outcomes
Weight maintenance
Measured via rate of weight loss (in lbs) following discharge from inpatient unit
Secondary outcomes
Habit strength
Measured via Self-Report Habit Index (SRHI)
Weight/shape distortion
Measured via Eating Disorder Examination, Questionnaire Version (EDE-Q)
Intrinsic motivation
Measured via General Self-Efficacy Scale (GSES)
Dietary restriction
Measured via Food Choice Task
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
New York State Psychiatric Institute
Lead sponsor
Columbia University
Collaborator
Brown University
Collaborator
National Institute of Mental Health (NIMH)
Collaborator